Sweden
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 714.00 M
|
Dec. 31, 2023 | USD 29.22 | -3.00% |
|
Sweden |
|
2 |
USD 301.33 M
|
Dec. 31, 2023 | USD 4.60 | 0.04% |
|
Sweden |
|
3 |
USD 284.11 M
|
Dec. 31, 2023 | USD 18.49 | 0.08% |
|
Sweden |
|
4 |
USD 225.13 M
|
Dec. 31, 2023 | USD 8.44 | 1.06% |
|
Sweden |
|
5 |
USD 188.01 M
|
Dec. 31, 2024 | USD 3.53 | -1.01% |
|
Sweden |
|
6 |
USD 152.59 M
|
Dec. 31, 2023 | USD 13.28 | -2.29% |
|
Sweden |
|
7 |
USD 76.36 M
|
Dec. 31, 2023 | USD 3.55 | -2.70% |
|
Sweden |
|
8 |
USD 55.52 M
|
Dec. 31, 2023 | USD 52.33 | -2.11% |
|
Sweden |
|
9 |
USD 45.11 M
|
Dec. 31, 2023 | USD 3.19 | -1.80% |
|
Sweden |
|
10 |
USD 41.59 M
|
Dec. 31, 2023 | USD 0.21 | -4.72% |
|
Sweden |
|
11 |
USD 29.15 M
|
Dec. 31, 2023 | USD 18.98 | -4.07% |
|
Sweden |
|
12 |
USD 20.46 M
|
Dec. 31, 2023 | USD 19.20 | -5.48% |
|
Sweden |
|
13 |
USD 14.62 M
|
Dec. 31, 2023 | USD 2.53 | -0.42% |
|
Sweden |
|
14 |
USD 7.95 M
|
Dec. 31, 2024 | USD 41.47 | -0.80% |
|
Sweden |
|
15 |
USD 6.51 M
|
Dec. 31, 2023 | USD 0.79 | -7.19% |
|
Sweden |
|
16 |
USD 6.37 M
|
Dec. 31, 2023 | USD 2.25 | -17.68% |
|
Sweden |
|
17 |
USD 6.32 M
|
Dec. 31, 2023 | USD 3.64 | -2.31% |
|
Sweden |
|
18 |
USD 5.53 M
|
Dec. 31, 2023 | USD 20.58 | -5.59% |
|
Sweden |
|
19 |
USD 3.10 M
|
Dec. 31, 2023 | USD 2.77 | -4.78% |
|
Sweden |
|
20 |
USD 717.15 K
|
Dec. 31, 2023 | USD 0.47 | -2.96% |
|
Sweden |
|
21 |
USD 177.07 K
|
Dec. 31, 2023 | USD 0.22 | -4.95% |
|
Sweden |
|
22 |
USD 4.15 K
|
Dec. 31, 2023 | USD 0.25 | -3.82% |
|
Sweden |
|
23 |
USD 197.40
|
Dec. 31, 2023 | USD 0.12 | -1.48% |
|
Sweden |
|
24 |
USD -166.41 K
|
Dec. 31, 2023 | USD 0.81 | -4.47% |
|
Sweden |
|
25 |
USD -205.30 K
|
Dec. 31, 2023 | USD 0.14 | 2.05% |
|
Sweden |
|
26 |
USD -383.05 K
|
Dec. 31, 2023 | USD 0.27 | -2.38% |
|
Sweden |
|
27 |
USD -869.79 K
|
Dec. 31, 2023 | USD 0.38 | -3.14% |
|
Sweden |
|
28 |
USD -1.21 M
|
April 30, 2024 | USD 0.13 | -1.11% |
|
Sweden |
|
29 |
USD -1.47 M
|
Dec. 31, 2023 | USD 0.16 | -2.74% |
|
Sweden |
|
30 |
USD -1.65 M
|
Dec. 31, 2023 | USD 0.84 | -2.95% |
|
Sweden |
|
31 |
USD -1.69 M
|
Dec. 31, 2023 | USD 0.31 | 1.24% |
|
Sweden |
|
32 |
USD -1.93 M
|
Dec. 31, 2023 | USD 0.09 | -2.04% |
|
Sweden |
|
33 |
USD -2.07 M
|
Dec. 31, 2023 | USD 0.18 | -3.03% |
|
Sweden |
|
34 |
USD -2.17 M
|
Dec. 31, 2023 | USD 1.64 | -3.31% |
|
Sweden |
|
35 |
USD -2.66 M
|
Dec. 31, 2023 | USD 0.85 | -1.32% |
|
Sweden |
|
36 |
USD -3.49 M
|
Dec. 31, 2023 | USD 0.39 | -4.99% |
|
Sweden |
|
37 |
USD -3.49 M
|
Dec. 31, 2023 | USD 0.21 | 1.47% |
|
Sweden |
|
38 |
USD -3.66 M
|
Dec. 31, 2023 | USD 1.25 | -0.41% |
|
Sweden |
|
39 |
USD -3.74 M
|
Dec. 31, 2023 | USD 0.12 | -10.10% |
|
Sweden |
|
40 |
USD -3.97 M
|
Aug. 31, 2024 | USD 0.26 | 0.92% |
|
Sweden |
|
41 |
USD -4.06 M
|
Dec. 31, 2023 | USD 0.13 | 0.88% |
|
Sweden |
|
42 |
USD -5.10 M
|
Dec. 31, 2023 | USD 1.59 | -2.74% |
|
Sweden |
|
43 |
USD -6.11 M
|
Dec. 31, 2023 | USD 0.09 | -2.98% |
|
Sweden |
|
44 |
USD -6.13 M
|
Dec. 31, 2023 | USD 0.19 | -8.49% |
|
Sweden |
|
45 |
USD -6.81 M
|
Dec. 31, 2023 | USD 0.09 | 11.18% |
|
Sweden |
|
46 |
USD -9.66 M
|
Dec. 31, 2023 | USD 0.71 | 8.98% |
|
Sweden |
|
47 |
USD -10.71 M
|
Dec. 31, 2023 | USD 0.26 | -2.13% |
|
Sweden |
|
48 |
USD -10.82 M
|
April 30, 2024 | USD 0.18 | -8.41% |
|
Sweden |
|
49 |
USD -11.34 M
|
Dec. 31, 2023 | USD 2.47 | -3.20% |
|
Sweden |
|
50 |
USD -11.73 M
|
Dec. 31, 2023 | USD 0.50 | -2.16% |
|
Sweden |
The Healthcare company in Sweden with the highest EBITDA is Swedish Orphan Biovitrum AB (publ) (Stockholm Stock Exchange: SOBI.ST) at USD 714.00 M.
The Healthcare company in Sweden with the lowest EBITDA is Vitrolife AB (publ) (Stockholm Stock Exchange: VITR.ST) at USD -314.36 M.
The top 10 Healthcare companies in Sweden by EBITDA are Swedish Orphan Biovitrum AB (publ), Attendo AB (publ), Medicover AB (publ), Ambea AB (publ), Arjo AB (publ), AddLife AB (publ), Vimian Group AB (publ), Camurus AB (publ), Humana AB (publ) and ADDvise Group AB (publ).
The bottom 10 Healthcare companies in Sweden by EBITDA are Vitrolife AB (publ), Hansa Biopharma AB (publ), Egetis Therapeutics AB (publ), Vicore Pharma Holding AB (publ), BioInvent International AB (publ), Cantargia AB (publ), Oncopeptides AB (publ), SynAct Pharma AB, IRLAB Therapeutics AB (publ) and Xspray Pharma AB (publ).